Edition:
United States

North China Pharmaceutical Co Ltd (600812.SS)

600812.SS on Shanghai Stock Exchange

5.84CNY
28 Jul 2017
Change (% chg)

¥0.00 (+0.00%)
Prev Close
¥5.84
Open
¥5.81
Day's High
¥5.86
Day's Low
¥5.81
Volume
3,882,106
Avg. Vol
14,942,767
52-wk High
¥7.60
52-wk Low
¥5.34

Latest Key Developments (Source: Significant Developments)

North China Pharmaceutical's unit receives GMP certificate
Monday, 17 Jul 2017 11:27pm EDT 

July 18 (Reuters) - North China Pharmaceutical Co Ltd <600812.SS> ::* Says co's pharmacy unit received goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration, for its sterile APIs (amoxicillin/sulbactam), with the valid period is until June 22, 2022.  Full Article

North China Pharmaceutical unit receives GMP certificate
Wednesday, 12 Jul 2017 01:47am EDT 

July 12 (Reuters) - North China Pharmaceutical Co Ltd <600812.SS> ::* Says co's unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration for its powder injection production line .  Full Article

North China Pharmaceutical issues 2017 1st tranche super short-term financing notes worth 1 bln yuan
Monday, 10 Jul 2017 03:03am EDT 

July 10(Reuters) - North China Pharmaceutical Co Ltd <600812.SS> ::* Says it issued 2017 1st tranche super short-term financing notes worth 1 billion yuan with a term of 270 days and interest rate of 5.3 percent.  Full Article

North China Pharmaceutical receives GMP certificate
Wednesday, 21 Jun 2017 04:25am EDT 

June 21(Reuters) - North China Pharmaceutical Co Ltd <600812.SS> ::* Says it received goods manufacture practice (GMP) certificate from Shijiazhuang Food and Drug Administration.* Says certificate issued to soft capsules, oral solution, granules, manufactured by the company and the valid period is until May 26, 2022.  Full Article

North China Pharmaceutical unit gets Certificate of Suitability to Monograph of European Pharmacopoeia
Sunday, 16 Apr 2017 10:35pm EDT 

April 17(Reuters) - North China Pharmaceutical Co Ltd <600812.SS>:Says wholly owned unit received Certificate of Suitability to Monograph of European Pharmacopoeia, from European Directorate for Quality of Medicines & HealthCare, for AMOXICILLIN TRIHYDRATE.Certificate valid for 5 years.  Full Article

North China Pharmaceutical receives GMP certificate
Wednesday, 22 Mar 2017 05:41am EDT 

North China Pharmaceutical Co Ltd <600812.SS> : Says it received goods manufacture practice(GMP) certificate from Hebei Food and Drug Administration on March 21 . Certificate issued to production line for manufacturing Amoxicillin Dispersible tablets, Amoxicillin and Clavulanate Potassium tablets and Amoxil capsule .Valid until Feb. 23, 2022.  Full Article

North China Pharma's chairman resigns due to personal reasons
Thursday, 9 Feb 2017 05:00am EST 

North China Pharmaceutical Co Ltd <600812.SS> :Says its Chairman Guo Zhouke resigns due to personal reasons.  Full Article

North China Pharmaceutical unit receives GMP certificate
Sunday, 8 Jan 2017 11:33pm EST 

North China Pharmaceutical Co Ltd <600812.SS> : Says its wholly owned pharma unit received goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration on Jan. 6 .Certificate issued to production line for manufacturing ciclosporin and the valid period is until Dec. 12, 2021.  Full Article

North China Pharmaceutical receives GMP certificate
Thursday, 8 Dec 2016 03:47am EST 

North China Pharmaceutical <600812.SS>: Says it received goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration on Dec. 5 .Certificate issued to tablets, hard capsules, oral solutions manufactured by the company and the valid period is until Nov. 14, 2021.  Full Article

North China Pharmaceutical gets approval for clinical trial
Wednesday, 26 Oct 2016 04:16am EDT 

North China Pharmaceutical Co Ltd <600812.SS>:Says it received approval from Food and Drug Administration Bureau on Oct. 25 for clinical trial of capecitabine tablets.  Full Article